{"id":"W4307906450","doi":"10.1016/s1470-2045(22)00629-5","title":"Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma","year":2022,"lang":"en","type":"letter","venue":"The Lancet Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pembrolizumab; Renal cell carcinoma; Adjuvant therapy; Oncology; Adjuvant; Internal medicine; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009298027,0.0009514613,0.002732058,0.0009679925,0.004772187,0.0074399,0.002497255,0.1115194,0.008372096],"category_scores_gemma":[0.04516473,0.00113819,0.002382752,0.0007762622,0.006322646,0.006505567,0.002762674,0.07749323,0.006376543],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00852864,"about_ca_system_score_gemma":0.008372615,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006454325,"about_ca_topic_score_gemma":0.01248425,"domain_scores_codex":[0.9916932,0.003323131,0.001254423,0.0007858059,0.001886707,0.00105674],"domain_scores_gemma":[0.9754109,0.01619826,0.001440519,0.0007486158,0.002654271,0.003547424],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000175352,0.0000401761,0.000317841,0.0001346244,0.00003340156,0.00144069,0.0001216402,0.0001237937,0.0003376715,0.00693153,0.9770045,0.01333889],"study_design_scores_gemma":[0.0004219196,0.00009658319,0.0008011744,0.0008691903,0.00008477844,0.00166039,0.0002388889,0.0005261478,0.0002390605,0.01818655,0.9767903,0.00008492629],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0001507905,0.002495314,0.00005568315,0.9796989,0.01555265,0.000006983055,0.00002648449,0.00001120362,0.002001923],"genre_scores_gemma":[0.002441381,0.001319344,0.0001932894,0.9356692,0.05670618,0.00003146545,0.00002726834,0.00002199569,0.003589948],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.1115194,"threshold_uncertainty_score":0.06187987,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06916348275263576,"score_gpt":0.317035747058509,"score_spread":0.2478722643058733,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}